Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms, Castration-Resistant × fludrocortisone acetate × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Prostatic Neoplasms, Castration-Resistant 1 Prostate Cancer Metastatic 1 Neoplasms 1

Interventions

Prednisone 6 enzalutamide 5 Docetaxel 4 Abiraterone Acetate 4 niraparib 2 darolutamide 2 abiraterone 2 olaparib 1 fludrocortisone acetate 1 cabazitaxel 1 Rosuvastatin Calcium 1 Pluvicto 1 Pioglitazone 1 Omeprazole 1 Nivolumab 1 Ipilimumab 1 Gonadotropin-Releasing Hormone 1 Dexamethasone 1 CTLA-4 Antigen 1 Artificial Intelligence 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06353386 2026-03-13

MK-5684-01A

Merck Sharp & Dohme LLC

Phase 1/2 Recruiting

Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡